Capitalizing on Cancer Specific Replication: Oncolytic Viruses as a Versatile Platform for the Enhancement of Cancer Immunotherapy Strategies

by Donald Bastin, Scott R. Walsh, Meena Al Saigh, Yonghong Wan
Published 2016-08-01

HDACi Delivery Reprograms Tumor-Infiltrating Myeloid Cells to Eliminate Antigen-Loss Variants

by Andrew Nguyen, Louisa Ho, Samuel T. Workenhe, Lan Chen, Jonathan Samson, Scott R. Walsh, Jonathan Pol, Jonathan L. Bramson, Yonghong Wan
Published 2018-07-01